Unite de Fabrication de Medicaments SA UMED
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 6.53%
- Dividend Yield (Forward)
- 6.53%
- Total Yield
- 6.53%
Company Profile
Unite de Fabrication de Medicaments SA develops drug production activity for human use in two areas namely Generic medicines and Fashioned drugs. The Company's products include Doperan, Furoxem 20, Levoject, Ketomed, among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- http://www.unimed.com.tn
Comparables
Valuation
|
Metric
|
UMED
|
SAH
|
UIB
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | — | — |
Price/Sales | — | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
UMED
SAH
UIB
Financial Strength
|
Metric
|
UMED
|
SAH
|
UIB
|
|---|---|---|---|
Quick Ratio | — | — | — |
Current Ratio | — | — | — |
Interest Coverage | — | — | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
UMED
|
SAH
|
UIB
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | 1.89% |
Return on Equity (Normalized) | — | — | 15.91% |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
UMED
SAH
UIB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Mgmbysjl | Rykhz | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Lqqvnmynz | Wnxln | $68.1 Bil | |
HLN
| Haleon PLC ADR | Htsbstxzb | Szxg | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zryskhcc | Fkbhz | $14.3 Bil | |
VTRS
| Viatris Inc | Lzklwzrr | Cct | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lsjjprgq | Xfhn | $11.9 Bil | |
CTLT
| Catalent Inc | Mnhksztc | Wpkcxh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rcvncnrh | Xkjn | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rjzrxpfj | Cbc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rzdtxkwnj | Rmsfvz | $3.4 Bil |